Impaction grafting in the femur in cementless modular revision total hip arthroplasty: a descriptive outcome analysis of 243 cases with the MRP-TITAN revision implant

• Published in: BMC musculoskeletal disorders 2013-01, Vol.14 (1), p.19-19, Article 19
• Main Authors: Wimmer, Matthias D, Randau, Thomas M, Deml, Moritz C, Ascherl, Rudolf, Nöth, Ulrich, Forst, Raimund, Gravius, Nadine, Wirtz, Dieter, Gravius, Sascha
• Format: Article
• Language: English
• Subjects: Aged; Analysis; Arthroplasty; Arthroplasty, Replacement, Hip - adverse effects; Arthroplasty, Replacement, Hip - instrumentation; Biomechanical Phenomena; Body mass index; Bone Transplantation - adverse effects; Bone-grafting; Colleges & universities; Defects; Design; Device Removal; Female; Femur; Femur - diagnostic imaging; Femur - surgery; Hip; Hip Joint - diagnostic imaging; Hip Joint - physiopathology; Hip Joint - surgery; Hip Prosthesis; Humans; Hypotheses; Impaction bone grafting; Joint surgery; Kaplan-Meier Estimate; Male; Middle Aged; Modular; Musculoskeletal diseases; Patients; Physiological aspects; Prosthesis Design; Prosthesis Failure; Radiography; Recovery of Function; Reoperation; Retrospective Studies; Revision; Surgery; Time Factors; Transplantation, Homologous; Transplants & implants; Treatment Outcome
• ISSN: 1471-2474; 1471-2474
• DOI: 10.1186/1471-2474-14-19

We present a descriptive and retrospective analysis of revision total hip arthroplasties (THA) using the MRP-TITAN stem (Peter Brehm, Weisendorf, GER) with distal diaphyseal fixation and metaphyseal defect augmentation. Our hypothesis was that the metaphyseal defect augmentation (Impaction Bone Grafting) improves the stem survival. We retrospectively analyzed the aggregated and anonymized data of 243 femoral stem revisions. 68 patients with 70 implants (28.8%) received an allograft augmentation for metaphyseal defects; 165 patients with 173 implants (71.2%) did not, and served as controls. The mean follow-up was 4.4 ± 1.8 years (range, 2.1-9.6 years). There were no significant differences (p > 0.05) between the study and control group regarding age, body mass index (BMI), femoral defects (types I-III as described by Paprosky), and preoperative Harris Hip Score (HHS). Postoperative clinical function was evaluated using the HHS. Postoperative radiologic examination evaluated implant stability, axial implant migration, signs of implant loosening, periprosthetic radiolucencies, as well as bone regeneration and resorption. There were comparable rates of intraoperative and postoperative complications in the study and control groups (p > 0.05). Clinical function, expressed as the increase in the postoperative HHS over the preoperative score, showed significantly greater improvement in the group with Impaction Bone Grafting (35.6 ± 14.3 vs. 30.8 ± 15.8; p ≤ 0.05). The study group showed better outcome especially for larger defects (types II C and III as described by Paprosky) and stem diameters ≥ 17 mm. The two groups did not show significant differences in the rate of aseptic loosening (1.4% vs. 2.9%) and the rate of revisions (8.6% vs. 11%). The Kaplan-Meier survival for the MRP-TITAN stem in both groups together was 93.8% after 8.8 years. [Study group 95.7% after 8.54 years ; control group 93.1% after 8.7 years]. Radiologic evaluation showed no significant change in axial implant migration (4.3% vs. 9.3%; p = 0.19) but a significant reduction in proximal stress shielding (5.7% vs. 17.9%; p < 0.05) in the study group. Periprosthetic radiolucencies were detected in 5.7% of the study group and in 9.8% of the control group (p = 0.30). Radiolucencies in the proximal zones 1 and 7 according to Gruen occurred significantly more often in the control group without allograft augmentation (p ≤ 0.05). We present the largest analysis of the impaction grafting technique in c